Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study).

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Abstract Text:

M R Cesarone,G Laurora,A Ricci,G Belcaro,P Pomante,C Candiani,M Leon,A N Nicolaides,

The acute effects of hydroxyethylrutosides on capillary filtration were studied in 12 normal subjects, 25 patients with venous hypertension and 22 diabetics with microangiopathy. The two groups of patients randomly received a single oral dose (500 or 1000 mg) of hydroxyethylrutosides. A single dose of 500 mg was used for normal volunteers. In the following 6 hours capillary filtration was studied with straingauge plethysmography. The decrease in capillary filtration was evident within the first hour and was at its peak between the second and fourth hour. After 6 hours it was still significantly below baseline values in patients. The 1000 mg dose was significantly more effective in both groups of patients. This study confirms the efficacy of hydroxyethylrutosides in decreasing capillary filtration. It suggests that the effect of one dose lasts at least 6 hours and also that the higher dose is more effective.

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Publishing Authors By Initials

MR Cesarone,G Laurora,A Ricci,G Belcaro,P Pomante,C Candiani,M Leon,AN Nicolaides,

For similar cardiovascular diseases: vascular diseases: venous insufficiency research abstracts see: cardiovascular diseases: vascular diseases: venous insufficiency research

PUBMED ID PMID:

MEDLINE DATE:

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: VASA. Zeitschrift für Gefässkrankheiten. Journal f

VOLUME: 21

Page Numbers: 76-80

Journal Abbreviation: VASA

ISSN: 0301-1526

DAY: 13

MONTH: 02

YEAR: 1992

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 317051

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Keywords Mesh Terms:

KEYWORDS: Venous Insufficiency

MESH TERMS: physiopathology

Chemical & Substance for Abstract: Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study). Information

Substance Name: Oxygen

Registry Number: 7782-44-7

Grant and Affiliation Information for Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study).

AFFILIATION: Microcirculation Laboratory, G. D'Annunzio University, Chieti, Italy.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Vasa

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy a dose comparison study Related Publications

• Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetuses.
• An integrated system for assessing stroke risk.
• An integrated system for the segmentation of atherosclerotic carotid plaque.
• Assessment of lung area in fetuses with congenital diaphragmatic hernia.
• Assessment of the corpus callosum at 20-24 weeks' gestation by three-dimensional ultrasound examination.
• Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome.
• First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
• Frontomaxillary facial angle in chromosomally normal fetuses at 11 + 0 to 13 + 6 weeks.
• Haemodynamic and rheological aspects of vascular grafts.
• Haemodynamic aspects of vascular grafting.
• Interleukin-9 upregulates mucus expression in the airways.
• Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
• Maternal cardiac function and uterine artery Doppler at 11-14 weeks in the prediction of pre-eclampsia in nulliparous women.
• Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.
• Maternal serum soluble adhesion molecule levels at 11(+0)-13(+6) weeks and subsequent development of pre-eclampsia.
• Multiscale morphological analysis of the atherosclerotic carotid plaque.
• Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy.
• OC140: Assessing the risk of spontaneous preterm birth using ultrasonic cervical length measurement and maternal characteristics.
• OC186: Cervical length at mid-gestation and the risk of primary Cesarean section at term.
• OC217: Results of fetal endoscopic tracheal occlusion beyond 29 weeks.
• OC218: Update on fetal endoscopic tracheal occlusion for severe left-sided isolated diaphragmatic hernia.
• P40.18: The antenatal and postnatal management in a case of pulmonary sequestration.
• P51.03: The management and treatment of fetal hemolytic disease due to anti-Ku alloimmunization with serial intrauterine transfusions to the fetus and recombinant erythropoietin to the mother.
• Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
• Some thoughts on the true value of ultrasound.
• The Immunogenic Potential of Generic Version of Low-Molecular-Weight Heparins May Not be the Same as the Branded Products.
• The incorporation in toto of octadecanoic acid (formed from ingested octadecane-1-C(14)) into the lipids of the sebaceous glands of the rat.
• The influence of medical and psychological interventions on women's distress after miscarriage.
• The monoene and other Wax alcohols of human skin surface lipid and their relation to the fatty acids of this lipid.
• Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia.